Advancing Neuroscience and Rare Disease Innovation

Oct 14, 07:53 PM

Headliner
Share
Subscribe

Acadia Pharmaceuticals’ CEO Catherine Owen Adams discusses the current climate in R&D and details her leadership style.

Share
Subscribe
Next
Pharmaceutical Executive Daily: Direct-To-Consumer Trends
Top episodes
Healthcare Marketing Strategies for Reaching Diverse Audiences
by Pharmaceutical Executive
Tariffs and Drug Prices: Understanding the Impact on Pharmaceuticals
by Pharmaceutical Executive
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
by Pharmaceutical Executive